Market Research Reports, Inc.

Global Frozen Pizza Market to Grow at a CAGR of 2.54% by 2019; Finds New Report

LogoReport forecast the Global Frozen Pizza market to grow at a CAGR of 2.54 percent in terms of revenue and 2.06 percent in terms of volume over the period 2014-2019.

Non-Life Insurance in South Korea Expected to Reach KRW41.5 Trillion (US$40.0 Billion) in 2018; Finds New Report

LogoThe report provides in-depth market analysis, information and insights into the South Korean non-life insurance segment, including:

Global Electric Power Steering Market to Grow at a CAGR of 8.63% by 2019; Finds New Report

LogoReport forecast the Global Electric Power Steering market to grow at a CAGR of 8.63 percent over the period 2014-2019.

Personal Accident and Health Insurance in South Korea Expected to Reach KRW43.4 Trillion (US$41.2 Billion) in 2018; Finds New Report

LogoThe report provides in-depth market analysis, information and insights into the South Korean personal accident and health insurance segment, including:

Low Iron Glass: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021; New Report Launched

LogoThe new study Low Iron Solar Glass: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. The 2015 study has 642 pages, 356 tables and figures. Worldwide markets for Low Iron Glass are growing as Concentrating Solar Power (CSP) takes off as a way to generate electricity. Rapid adoption of CSP worldwide is occurring as systems provide 24 hour per day power efficiently.

Japanese Military Expenditure Is Expected to Increase to US$46.4 Billion by 2020; Finds New Report

LogoThe Future of the Japanese Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2020,report provides readers with detailed analysis of both historic and forecast defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news.

Drone Launchers: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021; New Report Launched

LogoThe new study Drone Launchers: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021 has 393 pages, 150 tables and figures. Worldwide markets are poised to achieve significant growth as the drones market increases, bringing the need for launchers that do not use an airfield to get the aircraft airborne. Launchers provide a way to automate surveillance of wide areas and implement strategic military missions that strike at terrorists without injuring civilians.

Japan Pharma Outlook 2015: 2015 –Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives, New Report Launched

LogoThe new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating their domestic (and thus overseas) strategies to adopt with new regulations. For the innovators – testing Authorized Generics (AGs) phenomenon for protecting their long-listed sales against generic could be one of new choice in Japan. The format and regulations for AG's are still not clear in Japan, however with the largest Japanese product Blopress AG's launched recently and generic companies in queue to compete with their generic versions will make the things lucid for the fate of AG's in Japan.

Sri Lanka Pharma Market Outlook 2015: More Beyond Importers & Distributors, New Report Launched

LogoWith the recent development, Sri Lanka's aim of developing a pharma industry should be to penetrate the global market since the internal market is not sufficient for any big firm to operate at optimum levels. According to a report published by Indian Council on International Relations in Dec. '14, the global market of pharma is about $1trillion, and India's export of pharma products in 2013 amounted to $13bn, where as Sri Lanka was nil. Hence, pharma industry offers a very valuable opportunity for Sri Lanka to diversify its manufacturing and export base and thereby reach the goal of upper middle income country by 2020 and a rich country by 2035.

Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success, New Report Launched

LogoAll biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors. These companies have been able to select therapy/niche indication where the high treatment cost justifies the need. While large pharma companies are active in M&A deals, the Mature biotech companies are sticking to its core expertise and venturing into unexplored/new therapy; e.g., GILD in anti-cancer and BIIB for hemophilia.